Gastroenteropancreatic Neuroendocrine Tumors


Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2023 NANETS Multidisciplinary NET Medical Symposium

conference reporter by Jennifer R. Eads, MD; Thorvadur R. Halfdanarson, MD


Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Gastroenteropancreatic Neuroendocrine Tumors presented at this year’s 2023 NANETS Multidisciplinary NET Medical Symposium.


  • Advancing Neuroendocrine Tumor Research: Resources and Strategies 
  • Gastroenteropancreatic Neuroendocrine Tumors and the Current Treatment Landscape
  • Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials in Progress and Future Directions 
  • Interdisciplinary Perspectives and Joint Symposia on Neuroendocrine Tumors
  • Personalizing Therapy for Patients With Gastroenteropancreatic Neuroendocrine Tumors

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the North American Neuroendocrine Tumor Society.

Jennifer R. Eads, MD

Associate Professor of Clinical Medicine
Physician Lead, GI Clinical Research
Director, National Clinical Trials Network
Director, Penn Neuroendocrine Tumor Program
Division of Hematology and Oncology
University of Pennsylvania, Abramson Cancer Center
Perelman Center for Advanced Medicine
Philadelphia, PA

Thorvadur R. Halfdanarson, MD

Professor of Oncology
Mayo Clinic College of Medicine and Science
Consultant in Medical Oncology
Mayo Clinic
Rochester, MN